Need a vaccine booster against the corona virus? According to the FDA, Moderna does not meet the vaccine requirements – protection after two doses is adequate.
Summarize the essentials
- Moderna is unlikely to get approval for the booster vaccine in the United States.
- The reason: protection after two doses is adequate even after a long period of time.
The approval process for the third pix with vaccine from Moderna is currently underway in the United States. According to the Reuters news agency, the vaccine against the corona virus has not met the requirements for approval. This is because the effect is strong even after two doses.
The pharmaceutical company is accredited in the United States For the third dose Requested. It is half as strong as the first two doses. The US pharmaceutical company FDA is currently reviewing approval, and an official decision is still pending.
Corona virus: The effect is not enough
The booster vaccine also increases the number of antibodies present in Moderna. But the difference between the second and third vaccines is not enough. It lay Internal documents Close, it will be available to the news agency.
“Of course there was an effect. Was it increased enough? Who knows? There is no known standard size effect that is needed. And it is not clear how much motivation there is in this. Study It happened, ”John Moore wrote. He is Professor of Microbiology and Immunology at Weil Cornell Medical College in New York.